Meishangjie Biotechnology
Latest round
- Series A
Last raised
- Oct 2025
Total raised
- Undisclosed
Investors
- 5
About Meishangjie Biotechnology
Established in 2021 and based in Suzhou, China, Meishangjie Biotechnology is a genetic recombinant fibrillated collagen product development company. The company’s main business is in the innovation of biotechnological solutions, focusing on the synthesis of bio-active collagens. The company’s self-developed products include a range of anti-aging skincare products and Class II medical devices. Its products are used in the field of dermatology, ophthalmology, and surgical applications. Meishangjie Biotechnology generates revenue by offering synthetic biology skin care products and medical devices. The company plans to establish a new Class III medical device production line in Yixing, China.
Who invested in Meishangjie Biotechnology
5 investors across 2 rounds
See all investors in Meishangjie Biotechnology
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Meishangjie Biotechnology
Who invested in Meishangjie Biotechnology?
Meishangjie Biotechnology has 5 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Meishangjie Biotechnology raised?
Meishangjie Biotechnology has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Meishangjie Biotechnology last raise money?
Meishangjie Biotechnology's most recent round on record is a Series A, in Oct 2025.
What does Meishangjie Biotechnology do?
Established in 2021 and based in Suzhou, China, Meishangjie Biotechnology is a genetic recombinant fibrillated collagen product development company.
Where is Meishangjie Biotechnology headquartered?
Meishangjie Biotechnology is headquartered in Suzhou, China.
Which VCs invest in companies like Meishangjie Biotechnology?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at Meishangjie Biotechnology's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Meishangjie Biotechnology? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.